Last update July 23, 2022
Very Low Risk
We do not have alternatives for Carnitine since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Carnitine is also known as
Carnitine in other languages or writings:
Carnitine belongs to these groups or families:
Main tradenames from several countries containing Carnitine in its composition:
|Oral Bioavail.||5 - 18||%|
|Protein Binding||Bajo - Low||%|
|VD||0.2 - 0.4||l/Kg|
|T½||15 - 17||hours|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Carnitine is a derivative of the amino acids L-lysine and L-methionine. It is widely distributed in all mammalian tissues and is very abundant in muscle tissue and is essential in fatty acid metabolism (AESAN 2021). It is used as levocarnitine in the treatment of primary (extremely rare) and secondary deficiency (due to hemodialysis, cardiomyopathy or HIV) of carnitine (Evans 2003). Oral or intravenous administration 2 to 4 times a day. In the form of acetylcarnitine it is used in various psychiatric disorders.
Carnitine is present breast milk: Mean concentration level the first month is about 7 to 12 mg/L (Mitchell 1991, Penn 1987, Rovamo 1986, Cederblad 1986, Sandor 1982), with lower levels in the next following months. (Rovamo 1986, Sandor 1982)
Milk carnitine levels are not affected by carnitine supplementation: breastfed infants of carnitine-deficient mothers require carnitine supplementation. (Studinski 2011)
Due to its protein nature it would be digested and inactivated in the gastrointestinal tract. Its very low oral bioavailability, < 20% (Evans 2003), minimizes the passage into plasma of the infant from ingested breast milk, except in the premature and in the immediate neonatal period in which there may be greater intestinal permeability.
The maximum daily amount of levocarnitine as a food supplement should not exceed 2 g. (AESAN 2011)